Showing results (1-10 of 442) with videos related to
Sort By:
Pageof 45
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Alexander Bukreyev, Mario H Skiadopoulos, Josephine McAuliffe, et al.Journal of Virological Methods|January 11, 2007
An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trialsSonja R Surman, Peter L Collins, Brian R Murphy, et al.Virology Journal|September 26, 2008
Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infectionJoshua M DiNapoli, Brian R Murphy, Peter L Collins, et al.Journal of Virological Methods|June 16, 2005
Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expressionStéphane Biacchesi, Mario H Skiadopoulos, Lijuan Yang, et al.Journal of Virology|November 25, 2005
Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivoQuynh N Pham, Stéphane Biacchesi, Mario H Skiadopoulos, et al.Journal of Virology|December 13, 2002
The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutationsMario H Skiadopoulos, Leatrice Vogel, Jeffrey M Riggs, et al.Virology|March 31, 2004
Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genesStéphane Biacchesi, Mario H Skiadopoulos, Kim C Tran, et al.Journal of Virology|September 15, 2005
Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.Journal of Virology|May 30, 2006
Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.Virology Journal|July 4, 2007
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genesEmmalene J Bartlett, Adam Castaño, Sonja R Surman, et al.Pageof 45